标题
An update on blood-based biomarkers for non-Alzheimer neurodegenerative disorders
作者
关键词
-
出版物
Nature Reviews Neurology
Volume 16, Issue 5, Pages 265-284
出版商
Springer Science and Business Media LLC
发表日期
2020-04-23
DOI
10.1038/s41582-020-0348-0
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- Plasma glial fibrillary acidic protein is raised in progranulin-associated frontotemporal dementia
- (2020) Carolin Heller et al. JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY
- Plasma P-tau181 in Alzheimer’s disease: relationship to other biomarkers, differential diagnosis, neuropathology and longitudinal progression to Alzheimer’s dementia
- (2020) Shorena Janelidze et al. NATURE MEDICINE
- Diagnostic value of plasma phosphorylated tau181 in Alzheimer’s disease and frontotemporal lobar degeneration
- (2020) Elisabeth H. Thijssen et al. NATURE MEDICINE
- Blood phosphorylated tau 181 as a biomarker for Alzheimer's disease: a diagnostic performance and prediction modelling study using data from four prospective cohorts
- (2020) Thomas K Karikari et al. LANCET NEUROLOGY
- Glial Fibrillary Acidic Protein in Serum is Increased in Alzheimer’s Disease and Correlates with Cognitive Impairment
- (2019) Patrick Oeckl et al. JOURNAL OF ALZHEIMERS DISEASE
- Tau PET imaging in neurodegenerative tauopathies—still a challenge
- (2019) Antoine Leuzy et al. MOLECULAR PSYCHIATRY
- Genome-wide meta-analysis identifies new loci and functional pathways influencing Alzheimer’s disease risk
- (2019) Iris E. Jansen et al. NATURE GENETICS
- Serum neurofilament dynamics predicts neurodegeneration and clinical progression in presymptomatic Alzheimer’s disease
- (2019) Oliver Preische et al. NATURE MEDICINE
- Increased DJ-1 and α-Synuclein in Plasma Neural-Derived Exosomes as Potential Markers for Parkinson’s Disease
- (2019) Zhen-Hua Zhao et al. Frontiers in Aging Neuroscience
- Utility of Neuronal-Derived Exosomes to Examine Molecular Mechanisms That Affect Motor Function in Patients With Parkinson Disease
- (2019) Dilan Athauda et al. JAMA Neurology
- Increased plasma neurofilament light chain concentration correlates with severity of post-mortem neurofibrillary tangle pathology and neurodegeneration
- (2019) Nicholas J. Ashton et al. Acta Neuropathologica Communications
- Autoradiography validation of novel tau PET tracer [F-18]-MK-6240 on human postmortem brain tissue
- (2019) Cinthya Aguero et al. Acta Neuropathologica Communications
- A plasma protein classifier for predicting amyloid burden for preclinical Alzheimer’s disease
- (2019) Nicholas J. Ashton et al. Science Advances
- Assessment of Plasma Total Tau Level as a Predictive Biomarker for Dementia and Related Endophenotypes
- (2019) Matthew P. Pase et al. JAMA Neurology
- Urate and Homocysteine: Predicting Motor and Cognitive Changes in Newly Diagnosed Parkinson’s Disease
- (2019) Isobel Sleeman et al. Journal of Parkinsons Disease
- 18F-flortaucipir (AV-1451) tau PET in frontotemporal dementia syndromes
- (2019) Richard M. Tsai et al. Alzheimers Research & Therapy
- Systematic Review of miRNA as Biomarkers in Alzheimer’s Disease
- (2019) S. Swarbrick et al. MOLECULAR NEUROBIOLOGY
- Synaptic vesicle protein 2A as a potential biomarker in synaptopathies
- (2019) Kerstin Heurling et al. MOLECULAR AND CELLULAR NEUROSCIENCE
- α‐Synuclein real‐time quaking‐induced conversion in the cerebrospinal fluid of uncertain cases of parkinsonism
- (2019) Anouke van Rumund et al. ANNALS OF NEUROLOGY
- Neurofilament light chain as a biomarker in neurological disorders
- (2019) Lorenzo Gaetani et al. JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY
- Conversion to MCI and dementia in Parkinson's disease: a systematic review and meta-analysis
- (2019) Dimitrios Saredakis et al. PARKINSONISM & RELATED DISORDERS
- 18F-Flortaucipir in TDP-43 associated frontotemporal dementia
- (2019) R. Smith et al. Scientific Reports
- Advantages and disadvantages of the use of the CSF Amyloid β (Aβ) 42/40 ratio in the diagnosis of Alzheimer’s Disease
- (2019) Oskar Hansson et al. Alzheimers Research & Therapy
- Association Between Longitudinal Plasma Neurofilament Light and Neurodegeneration in Patients With Alzheimer Disease
- (2019) Niklas Mattsson et al. JAMA Neurology
- Correlations between serum and CSF pNfH levels in ALS, FTD and controls: a comparison of three analytical approaches
- (2019) Carlo Wilke et al. CLINICAL CHEMISTRY AND LABORATORY MEDICINE
- Neurofilament levels in patients with neurological diseases: A comparison of neurofilament light and heavy chain levels
- (2019) Pavlína Kušnierová et al. JOURNAL OF CLINICAL LABORATORY ANALYSIS
- Performance of Fully Automated Plasma Assays as Screening Tests for Alzheimer Disease–Related β-Amyloid Status
- (2019) Sebastian Palmqvist et al. JAMA Neurology
- Establishment of neurofilament light chain Simoa assay in cerebrospinal fluid and blood
- (2019) Robert Hendricks et al. Bioanalysis
- Neurofilaments in pre-symptomatic ALS and the impact of genotype
- (2019) Michael Benatar et al. Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration
- Serum Neurofilament Light Chain Levels in Patients With Presymptomatic Multiple Sclerosis
- (2019) Kjetil Bjornevik et al. JAMA Neurology
- Cerebrospinal fluid and plasma biomarker trajectories with increasing amyloid deposition in Alzheimer's disease
- (2019) Sebastian Palmqvist et al. EMBO Molecular Medicine
- Association between plasma GFAP concentrations and MRI abnormalities in patients with CT-negative traumatic brain injury in the TRACK-TBI cohort: a prospective multicentre study
- (2019) John K Yue et al. LANCET NEUROLOGY
- α‐Synuclein RT‐QuIC assay in cerebrospinal fluid of patients with dementia with Lewy bodies
- (2019) Matilde Bongianni et al. Annals of Clinical and Translational Neurology
- Cerebrospinal fluid levels of neurogranin in Parkinsonian disorders
- (2019) Sara Hall et al. MOVEMENT DISORDERS
- Cerebrospinal fluid neurogranin concentration in neurodegeneration: relation to clinical phenotypes and neuropathology
- (2018) Erik Portelius et al. ACTA NEUROPATHOLOGICA
- Plasma phospho-tau181 increases with Alzheimer's disease clinical severity and is associated with tau- and amyloid-positron emission tomography
- (2018) Michelle M. Mielke et al. Alzheimers & Dementia
- NIA-AA Research Framework: Toward a biological definition of Alzheimer's disease
- (2018) Clifford R. Jack et al. Alzheimers & Dementia
- The Glymphatic System in Central Nervous System Health and Disease: Past, Present, and Future
- (2018) Benjamin A. Plog et al. Annual Review of Pathology-Mechanisms of Disease
- Update on biomarkers for amyloid pathology in Alzheimer's disease
- (2018) Nicholas J Ashton et al. Biomarkers in Medicine
- Serum metabolomics study in a group of Parkinson's disease patients from northern India
- (2018) G. Nagesh Babu et al. CLINICA CHIMICA ACTA
- Commutability of the certified reference materials for the standardization of β-amyloid 1-42 assay in human cerebrospinal fluid: lessons for tau and β-amyloid 1-40 measurements
- (2018) Ulf Andreasson et al. CLINICAL CHEMISTRY AND LABORATORY MEDICINE
- Assay of Plasma Phosphorylated Tau Protein (Threonine 181) and Total Tau Protein in Early-Stage Alzheimer’s Disease
- (2018) Che-Chuan Yang et al. JOURNAL OF ALZHEIMERS DISEASE
- Potential biomarkers of Parkinson's disease revealed by plasma metabolic profiling
- (2018) Huiyuan Zhao et al. JOURNAL OF CHROMATOGRAPHY B-ANALYTICAL TECHNOLOGIES IN THE BIOMEDICAL AND LIFE SCIENCES
- Neurofilament light chain and tau concentrations are markedly increased in the serum of patients with sporadic Creutzfeldt-Jakob disease, and tau correlates with rate of disease progression
- (2018) Andrew Geoffrey Bourne Thompson et al. JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY
- Plasma tau is increased in frontotemporal dementia
- (2018) Martha S Foiani et al. JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY
- First in-human PET study of 3 novel tau radiopharmaceuticals: [11C]RO6924963, [11C]RO6931643, and [18F]RO6958948
- (2018) Dean F. Wong et al. JOURNAL OF NUCLEAR MEDICINE
- Alternations of Metabolic Profile and Kynurenine Metabolism in the Plasma of Parkinson’s Disease
- (2018) Kuo-Hsuan Chang et al. MOLECULAR NEUROBIOLOGY
- High performance plasma amyloid-β biomarkers for Alzheimer’s disease
- (2018) Akinori Nakamura et al. NATURE
- No association of salivary total tau concentration with Alzheimer's disease
- (2018) Nicholas J. Ashton et al. NEUROBIOLOGY OF AGING
- The relation between plasma α-synuclein level and clinical symptoms or signs of Parkinson's disease
- (2018) Michalina Malec-Litwinowicz et al. Neurologia i Neurochirurgia Polska
- Plasma neurofilament light chain concentration in the inherited peripheral neuropathies
- (2018) Åsa Sandelius et al. NEUROLOGY
- Serum neurofilament light chain in progressive supranuclear palsy
- (2018) Laura Donker Kaat et al. PARKINSONISM & RELATED DISORDERS
- Neurofilament light as a blood biomarker for neurodegeneration in Down syndrome
- (2018) Andre Strydom et al. Alzheimers Research & Therapy
- Plasma Biomarkers Differentiate Parkinson’s Disease From Atypical Parkinsonism Syndromes
- (2018) Chin-Hsien Lin et al. Frontiers in Aging Neuroscience
- Promising Metabolite Profiles in the Plasma and CSF of Early Clinical Parkinson's Disease
- (2018) Daniel Stoessel et al. Frontiers in Aging Neuroscience
- Association of Changes in Plasma Neurofilament Light and Tau Levels With Anesthesia and Surgery
- (2018) Lisbeth Evered et al. JAMA Neurology
- α-Synuclein Heterocomplexes with β-Amyloid Are Increased in Red Blood Cells of Parkinson’s Disease Patients and Correlate with Disease Severity
- (2018) Simona Daniele et al. Frontiers in Molecular Neuroscience
- Rapid and ultra-sensitive quantitation of disease-associated α-synuclein seeds in brain and cerebrospinal fluid by αSyn RT-QuIC
- (2018) Bradley R. Groveman et al. Acta Neuropathologica Communications
- Validation of a Multiplex Assay for Simultaneous Quantification of Amyloid-β Peptide Species in Human Plasma with Utility for Measurements in Studies of Alzheimer's Disease Therapeutics
- (2018) D. Richard Lachno et al. JOURNAL OF ALZHEIMERS DISEASE
- Cerebrospinal Fluid Levels of Heart Fatty Acid Binding Protein are Elevated Prodromally in Alzheimer's Disease and Vascular Dementia
- (2018) Bob Olsson et al. JOURNAL OF ALZHEIMERS DISEASE
- A Selected Reaction Monitoring (SRM)-Based Method for Absolute Quantification of Aβ38, Aβ40, and Aβ42 in Cerebrospinal Fluid of Alzheimer's Disease Patients and Healthy Controls
- (2018) Josef Pannee et al. JOURNAL OF ALZHEIMERS DISEASE
- Plasma and CSF biomarkers for the diagnosis of Alzheimer's disease in adults with Down syndrome: a cross-sectional study
- (2018) Juan Fortea et al. LANCET NEUROLOGY
- Neurofilaments as biomarkers in neurological disorders
- (2018) Michael Khalil et al. Nature Reviews Neurology
- 18F-AV-1451 in Parkinson’s Disease with and without dementia and in Dementia with Lewy Bodies
- (2018) Ruben Smith et al. Scientific Reports
- Plasma neurofilament light as a potential biomarker of neurodegeneration in Alzheimer’s disease
- (2018) Piotr Lewczuk et al. Alzheimers Research & Therapy
- Clustering Analysis of FDG-PET Imaging in Primary Progressive Aphasia
- (2018) Jordi A. Matias-Guiu et al. Frontiers in Aging Neuroscience
- Current state of Alzheimer’s fluid biomarkers
- (2018) José Luis Molinuevo et al. ACTA NEUROPATHOLOGICA
- Novel tau fragments in cerebrospinal fluid: relation to tangle pathology and cognitive decline in Alzheimer’s disease
- (2018) Claudia Cicognola et al. ACTA NEUROPATHOLOGICA
- Learnings about the complexity of extracellular tau aid development of a blood-based screen for Alzheimer's disease
- (2018) Zhicheng Chen et al. Alzheimers & Dementia
- Elevated CSF GAP-43 is Alzheimer's disease specific and associated with tau and amyloid pathology
- (2018) Åsa Sandelius et al. Alzheimers & Dementia
- Neurofilament light chain in serum for the diagnosis of amyotrophic lateral sclerosis
- (2018) Federico Verde et al. JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY
- Biomarkers for tau pathology
- (2018) Michael Schöll et al. MOLECULAR AND CELLULAR NEUROSCIENCE
- Blood-based biomarkers for Alzheimer disease: mapping the road to the clinic
- (2018) Harald Hampel et al. Nature Reviews Neurology
- Review: Fluid biomarkers for frontotemporal dementias
- (2018) H. Zetterberg et al. NEUROPATHOLOGY AND APPLIED NEUROBIOLOGY
- Plasma Protein Biomarkers for the Prediction of CSF Amyloid and Tau and [18F]-Flutemetamol PET Scan Result
- (2018) Sarah Westwood et al. Frontiers in Aging Neuroscience
- Magnetic resonance imaging for the diagnosis of Parkinson’s disease
- (2017) Beatrice Heim et al. JOURNAL OF NEURAL TRANSMISSION
- Peripheral inflammation in prodromal Alzheimer’s and Lewy body dementias
- (2017) Eleanor King et al. JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY
- Plasma α-synuclein predicts cognitive decline in Parkinson’s disease
- (2017) Chin-Hsien Lin et al. JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY
- Patterns of atrophy in pathologically confirmed dementias: a voxelwise analysis
- (2017) Lorna Harper et al. JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY
- Comparison of elevated phosphorylated neurofilament heavy chains in serum and cerebrospinal fluid of patients with amyotrophic lateral sclerosis
- (2017) Maxim De Schaepdryver et al. JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY
- 18F-FDG PET in Parkinsonism: Differential Diagnosis and Evaluation of Cognitive Impairment
- (2017) Philipp T. Meyer et al. JOURNAL OF NUCLEAR MEDICINE
- Reduced mitochondrial mRNA expression in dementia with Lewy bodies
- (2017) Michele Salemi et al. JOURNAL OF THE NEUROLOGICAL SCIENCES
- Quantification of plasma phosphorylated tau to use as a biomarker for brain Alzheimer pathology: pilot case-control studies including patients with Alzheimer’s disease and down syndrome
- (2017) Harutsugu Tatebe et al. Molecular Neurodegeneration
- Clinical diagnosis of progressive supranuclear palsy: The movement disorder society criteria
- (2017) Günter U. Höglinger et al. MOVEMENT DISORDERS
- Profiling novel metabolic biomarkers for Parkinson's disease using in-depth metabolomic analysis
- (2017) Wei Han et al. MOVEMENT DISORDERS
- Diagnostic utility of cerebrospinal fluid α-synuclein in Parkinson's disease: A systematic review and meta-analysis
- (2017) Paolo Eusebi et al. MOVEMENT DISORDERS
- Plasma neurofilament light chain levels in patients with MS switching from injectable therapies to fingolimod
- (2017) Fredrik Piehl et al. Multiple Sclerosis Journal
- [18F]FDG PET signal is driven by astroglial glutamate transport
- (2017) Eduardo R Zimmer et al. NATURE NEUROSCIENCE
- Cognitive decline in Parkinson disease
- (2017) Dag Aarsland et al. Nature Reviews Neurology
- Serum neurofilament light is sensitive to active cerebral small vessel disease
- (2017) Thomas Gattringer et al. NEUROLOGY
- Analysis of blood-based gene expression in idiopathic Parkinson disease
- (2017) Ron Shamir et al. NEUROLOGY
- Diagnosis and management of dementia with Lewy bodies
- (2017) Ian G. McKeith et al. NEUROLOGY
- CSF neurofilament light chain and phosphorylated tau 181 predict disease progression in PSP
- (2017) Julio C. Rojas et al. NEUROLOGY
- Serum neurofilament light in familial Alzheimer disease
- (2017) Philip S.J. Weston et al. NEUROLOGY
- Monitoring disease activity in multiple sclerosis using serum neurofilament light protein
- (2017) Lenka Novakova et al. NEUROLOGY
- Blood-based NfL
- (2017) Oskar Hansson et al. NEUROLOGY
- Multicenter evaluation of neurofilaments in early symptom onset amyotrophic lateral sclerosis
- (2017) Emily Feneberg et al. NEUROLOGY
- Serum neurofilament light as a biomarker for mild traumatic brain injury in contact sports
- (2017) Pashtun Shahim et al. NEUROLOGY
- Review: Tau in biofluids - relation to pathology, imaging and clinical features
- (2017) H. Zetterberg NEUROPATHOLOGY AND APPLIED NEUROBIOLOGY
- Mass Spectrometric Analysis of Cerebrospinal Fluid Ubiquitin in Alzheimer's Disease and Parkinsonian Disorders
- (2017) Simon Sjödin et al. Proteomics Clinical Applications
- Analytical performance of reagent for assaying tau protein in human plasma and feasibility study screening neurodegenerative diseases
- (2017) Shieh-Yueh Yang et al. Scientific Reports
- High diagnostic value of second generation CSF RT-QuIC across the wide spectrum of CJD prions
- (2017) Alessia Franceschini et al. Scientific Reports
- Circulating brain-enriched microRNAs as novel biomarkers for detection and differentiation of neurodegenerative diseases
- (2017) Kira S. Sheinerman et al. Alzheimers Research & Therapy
- Perspective Insights of Exosomes in Neurodegenerative Diseases: A Critical Appraisal
- (2017) Arif Tasleem Jan et al. Frontiers in Aging Neuroscience
- Association of Plasma Total Tau Level With Cognitive Decline and Risk of Mild Cognitive Impairment or Dementia in the Mayo Clinic Study on Aging
- (2017) Michelle M. Mielke et al. JAMA Neurology
- Association of Plasma Neurofilament Light With Neurodegeneration in Patients With Alzheimer Disease
- (2017) Niklas Mattsson et al. JAMA Neurology
- Plasma neurofilament light chain levels in patients with MS switching from injectable therapies to fingolimod
- (2017) Fredrik Piehl et al. Multiple Sclerosis Journal
- Performance Characteristics of Plasma Amyloid-β 40 and 42 Assays
- (2017) Olivia I. Okereke et al. JOURNAL OF ALZHEIMERS DISEASE
- Posttranslational modifications of blood-derived alpha-synuclein as biochemical markers for Parkinson’s disease
- (2017) Hugo Vicente Miranda et al. Scientific Reports
- Monomethylated and unmethylated FUS exhibit increased binding to Transportin and distinguish FTLD-FUS from ALS-FUS
- (2016) Marc Suárez-Calvet et al. ACTA NEUROPATHOLOGICA
- In vivoimaging of neuromelanin in Parkinson’s disease using18F-AV-1451 PET
- (2016) Allan K. Hansen et al. BRAIN
- Different FDG-PET metabolic patterns at single-subject level in the behavioral variant of fronto-temporal dementia
- (2016) Chiara Cerami et al. CORTEX
- Decreased synaptic proteins in neuronal exosomes of frontotemporal dementia and Alzheimer’s disease
- (2016) Edward J. Goetzl et al. FASEB JOURNAL
- Cargo proteins of plasma astrocyte-derived exosomes in Alzheimer’s disease
- (2016) Edward J. Goetzl et al. FASEB JOURNAL
- Blood-Based Biomarker Candidates of Cerebral Amyloid Using PiB PET in Non-Demented Elderly
- (2016) Sarah Westwood et al. JOURNAL OF ALZHEIMERS DISEASE
- Cerebrospinal Fluid Alzheimer’s Disease Biomarkers Across the Spectrum of Lewy Body Diseases: Results from a Large Multicenter Cohort
- (2016) Inger van Steenoven et al. JOURNAL OF ALZHEIMERS DISEASE
- Positron emission tomography imaging of tau pathology in progressive supranuclear palsy
- (2016) Sarah Coakeley et al. JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM
- Neurochemical biomarkers in the diagnosis of frontotemporal lobar degeneration: an update
- (2016) Patrick Oeckl et al. JOURNAL OF NEUROCHEMISTRY
- The clinical spectrum of sporadic and familial forms of frontotemporal dementia
- (2016) Ione O. C. Woollacott et al. JOURNAL OF NEUROCHEMISTRY
- Molecular neuropathology of frontotemporal dementia: insights into disease mechanisms from postmortem studies
- (2016) Ian R. A. Mackenzie et al. JOURNAL OF NEUROCHEMISTRY
- Neurofilament light chain in FTD is elevated not only in cerebrospinal fluid, but also in serum
- (2016) Carlo Wilke et al. JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY
- Altered Proteins in the Aging Brain
- (2016) Adila Elobeid et al. JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY
- CSF and blood biomarkers for the diagnosis of Alzheimer's disease: a systematic review and meta-analysis
- (2016) Bob Olsson et al. LANCET NEUROLOGY
- Multi-platform mass spectrometry analysis of the CSF and plasma metabolomes of rigorously matched amyotrophic lateral sclerosis, Parkinson's disease and control subjects
- (2016) Anna Wuolikainen et al. Molecular BioSystems
- Imaging synucleinopathies
- (2016) David J. Brooks et al. MOVEMENT DISORDERS
- Increased basal ganglia binding of18F-AV-1451 in patients with progressive supranuclear palsy
- (2016) Ruben Smith et al. MOVEMENT DISORDERS
- Extracellular vesicles in neurodegenerative disease — pathogenesis to biomarkers
- (2016) Alexander G. Thompson et al. Nature Reviews Neurology
- A comparative study of the amount of α-synuclein in ischemic stroke and Parkinson’s disease
- (2016) Hui-Qing Zhao et al. NEUROLOGICAL SCIENCES
- Plasma tau in Alzheimer disease
- (2016) Niklas Mattsson et al. NEUROLOGY
- Serum neurofilament light chain protein is a measure of disease intensity in frontotemporal dementia
- (2016) Jonathan D. Rohrer et al. NEUROLOGY
- DNA methylation changes atSNCAintron 1 in patients with dementia with Lewy bodies
- (2016) Yu Funahashi et al. PSYCHIATRY AND CLINICAL NEUROSCIENCES
- The pre-synaptic vesicle protein synaptotagmin is a novel biomarker for Alzheimer’s disease
- (2016) Annika Öhrfelt et al. Alzheimers Research & Therapy
- Plasma neuronal exosomal levels of Alzheimer's disease biomarkers in normal aging
- (2016) Erin L. Abner et al. Annals of Clinical and Translational Neurology
- Plasma neurofilament light chain predicts progression in progressive supranuclear palsy
- (2016) Julio C. Rojas et al. Annals of Clinical and Translational Neurology
- Alpha-synuclein RT-QuIC in the CSF of patients with alpha-synucleinopathies
- (2016) Graham Fairfoul et al. Annals of Clinical and Translational Neurology
- Neurofilament light chain: a biomarker for genetic frontotemporal dementia
- (2016) Lieke H. Meeter et al. Annals of Clinical and Translational Neurology
- The Genetic Basis of Cognitive Impairment and Dementia in Parkinson’s Disease
- (2016) Lucy M. Collins et al. Frontiers in Psychiatry
- Plasma Concentration of the Neurofilament Light Protein (NFL) is a Biomarker of CNS Injury in HIV Infection: A Cross-Sectional Study
- (2016) Magnus Gisslén et al. EBioMedicine
- miRNA expression profiles in cerebrospinal fluid and blood of patients with Alzheimer’s disease and other types of dementia – an exploratory study
- (2016) Sofie Sølvsten Sørensen et al. Translational Neurodegeneration
- An autoradiographic evaluation of AV-1451 Tau PET in dementia
- (2016) Val J. Lowe et al. Acta Neuropathologica Communications
- Plasma β-amyloid in Alzheimer’s disease and vascular disease
- (2016) Shorena Janelidze et al. Scientific Reports
- Neurofilaments in blood and CSF for diagnosis and prediction of onset in Creutzfeldt-Jakob disease
- (2016) Petra Steinacker et al. Scientific Reports
- Cerebrospinal fluid levels of the synaptic protein neurogranin correlates with cognitive decline in prodromal Alzheimer's disease
- (2015) Hlin Kvartsberg et al. Alzheimers & Dementia
- C-terminal neurogranin is increased in cerebrospinal fluid but unchanged in plasma in Alzheimer's disease
- (2015) Ann De Vos et al. Alzheimers & Dementia
- Identification of preclinical Alzheimer's disease by a profile of pathogenic proteins in neurally derived blood exosomes: A case-control study
- (2015) Massimo S. Fiandaca et al. Alzheimers & Dementia
- MicroRNA association with synucleinopathy conversion in rapid eye movement behavior disorder
- (2015) Rubén Fernández-Santiago et al. ANNALS OF NEUROLOGY
- Oligomeric α-synuclein and β-amyloid variants as potential biomarkers for Parkinson's and Alzheimer's diseases
- (2015) Stephanie M. Williams et al. EUROPEAN JOURNAL OF NEUROSCIENCE
- Visual and statistical analysis of 18F-FDG PET in primary progressive aphasia
- (2015) Jordi A. Matías-Guiu et al. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
- Dysfunctionally phosphorylated type 1 insulin receptor substrate in neural-derived blood exosomes of preclinical Alzheimer’s disease
- (2015) Dimitrios Kapogiannis et al. FASEB JOURNAL
- Identification of novel biomarkers for Parkinson's disease by metabolomic technologies
- (2015) Taku Hatano et al. JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY
- Frontotemporal dementia
- (2015) Jee Bang et al. LANCET
- Integrated isolation and quantitative analysis of exosome shuttled proteins and nucleic acids using immunocapture approaches
- (2015) Natasa Zarovni et al. METHODS
- Cerebrospinal Fluid Peptides as Potential Parkinson Disease Biomarkers: A Staged Pipeline for Discovery and Validation
- (2015) Min Shi et al. MOLECULAR & CELLULAR PROTEOMICS
- Identification of novel CSF biomarkers for neurodegeneration and their validation by a high-throughput multiplexed targeted proteomic assay
- (2015) Wendy E. Heywood et al. Molecular Neurodegeneration
- Amyloid deposition in Parkinson's disease and cognitive impairment: A systematic review
- (2015) Myria Petrou et al. MOVEMENT DISORDERS
- MDS clinical diagnostic criteria for Parkinson's disease
- (2015) Ronald B. Postuma et al. MOVEMENT DISORDERS
- Clearance systems in the brain—implications for Alzheimer disease
- (2015) Jenna M. Tarasoff-Conway et al. Nature Reviews Neurology
- PET Radioligands Reveal the Basis of Dementia in Parkinson's Disease and Dementia with Lewy Bodies
- (2015) Stephen N. Gomperts et al. Neurodegenerative Diseases
- Detection of α-synuclein oligomers in red blood cells as a potential biomarker of Parkinson’s disease
- (2015) Xuemei Wang et al. NEUROSCIENCE LETTERS
- Tissue-based map of the human proteome
- (2015) M. Uhlen et al. SCIENCE
- Characterization of the postsynaptic protein neurogranin in paired cerebrospinal fluid and plasma samples from Alzheimer’s disease patients and healthy controls
- (2015) Hlin Kvartsberg et al. Alzheimers Research & Therapy
- Neurogranin as a Cerebrospinal Fluid Biomarker for Synaptic Loss in Symptomatic Alzheimer Disease
- (2015) Maartje I. Kester et al. JAMA Neurology
- Exosome and Exosomal MicroRNA: Trafficking, Sorting, and Function
- (2015) Jian Zhang et al. GENOMICS PROTEOMICS & BIOINFORMATICS
- Decrease in Plasma Levels of α-Synuclein Is Evident in Patients with Parkinson’s Disease after Elimination of Heterophilic Antibody Interference
- (2015) Ryotaro Ishii et al. PLoS One
- Levels and Age Dependency of Neurofilament Light and Glial Fibrillary Acidic Protein in Healthy Individuals and Their Relation to the Brain Parenchymal Fraction
- (2015) Mattias Vågberg et al. PLoS One
- Alpha-synuclein in peripheral tissues and body fluids as a biomarker for Parkinson's disease - a systematic review
- (2014) N. Malek et al. ACTA NEUROLOGICA SCANDINAVICA
- Plasma exosomal α-synuclein is likely CNS-derived and increased in Parkinson’s disease
- (2014) Min Shi et al. ACTA NEUROPATHOLOGICA
- Plasma proteins predict conversion to dementia from prodromal disease
- (2014) Abdul Hye et al. Alzheimers & Dementia
- Cerebrospinal fluid alpha-synuclein as a biomarker for Parkinson's disease diagnosis: a systematic review and meta-analysis
- (2014) Liang Gao et al. INTERNATIONAL JOURNAL OF NEUROSCIENCE
- Divergent CSF alterations in two common tauopathies: Alzheimer's disease and progressive supranuclear palsy
- (2014) D. Wagshal et al. JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY
- Advancing research diagnostic criteria for Alzheimer's disease: the IWG-2 criteria
- (2014) Bruno Dubois et al. LANCET NEUROLOGY
- SNAP-25 is a promising novel cerebrospinal fluid biomarker for synapse degeneration in Alzheimer’s disease
- (2014) Ann Brinkmalm et al. Molecular Neurodegeneration
- Plasma phospholipids identify antecedent memory impairment in older adults
- (2014) Mark Mapstone et al. NATURE MEDICINE
- Frontotemporal Lobar Degeneration: A Clinical Approach
- (2014) Elissaios Karageorgiou et al. SEMINARS IN NEUROLOGY
- The role of extracellular vesicles in the progression of neurodegenerative disease and cancer
- (2014) Kate M. Candelario et al. TRENDS IN MOLECULAR MEDICINE
- Levels of cerebrospinal fluid α-synuclein oligomers are increased in Parkinson’s disease with dementia and dementia with Lewy bodies compared to Alzheimer’s disease
- (2014) Oskar Hansson et al. Alzheimers Research & Therapy
- Limited role of free TDP-43 as a diagnostic tool in neurodegenerative diseases
- (2014) Emily Feneberg et al. Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration
- Blood Biomarkers for Brain Injury in Concussed Professional Ice Hockey Players
- (2014) Pashtun Shahim et al. JAMA Neurology
- Increased microRNA-34c abundance in Alzheimer's disease circulating blood plasma
- (2014) Shephali Bhatnagar et al. Frontiers in Molecular Neuroscience
- Heterophilic antibody interference in immunometric assays
- (2013) Nils Bolstad et al. BEST PRACTICE & RESEARCH CLINICAL ENDOCRINOLOGY & METABOLISM
- Distinct α-Synuclein Strains Differentially Promote Tau Inclusions in Neurons
- (2013) Jing L. Guo et al. CELL
- The impact of pre-analytical variables on the stability of neurofilament proteins in CSF, determined by a novel validated SinglePlex Luminex assay and ELISA
- (2013) Marleen J.A. Koel-Simmelink et al. JOURNAL OF IMMUNOLOGICAL METHODS
- Plasma phosphorylated TDP-43 levels are elevated in patients with frontotemporal dementia carrying a C9orf72 repeat expansion or a GRN mutation
- (2013) M. Suarez-Calvet et al. JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY
- Circulating miR-125b as a biomarker of Alzheimer's disease
- (2013) Lin Tan et al. JOURNAL OF THE NEUROLOGICAL SCIENCES
- Heart fatty acid binding protein and Aβ-associated Alzheimer’s neurodegeneration
- (2013) Rahul S Desikan et al. Molecular Neurodegeneration
- A blood-based predictor for neocortical Aβ burden in Alzheimer’s disease: results from the AIBL study
- (2013) S C Burnham et al. MOLECULAR PSYCHIATRY
- 3-hydroxykynurenine and other Parkinson's disease biomarkers discovered by metabolomic analysis
- (2013) Peter A. LeWitt et al. MOVEMENT DISORDERS
- A comparative study of CSF neurofilament light and heavy chain protein in MS
- (2013) Jens Kuhle et al. Multiple Sclerosis Journal
- Autonomic disorders predicting Parkinson's disease
- (2013) Jose-Alberto Palma et al. PARKINSONISM & RELATED DISORDERS
- Identification of Altered Metabolic Pathways in Plasma and CSF in Mild Cognitive Impairment and Alzheimer’s Disease Using Metabolomics
- (2013) Eugenia Trushina et al. PLoS One
- Circulating miRNA Biomarkers for Alzheimer's Disease
- (2013) Pavan Kumar et al. PLoS One
- A longitudinal study on α-synuclein in blood plasma as a biomarker for Parkinson's disease
- (2013) Penelope G. Foulds et al. Scientific Reports
- Plasma tau levels in Alzheimer's disease
- (2013) Henrik Zetterberg et al. Alzheimers Research & Therapy
- A blood based 12-miRNA signature of Alzheimer disease patients
- (2013) Petra Leidinger et al. GENOME BIOLOGY
- TDP-43 plasma levels are higher in amyotrophic lateral sclerosis
- (2012) Esther Verstraete et al. Amyotrophic Lateral Sclerosis
- Neuropathologic substrates of Parkinson disease dementia
- (2012) David J. Irwin et al. ANNALS OF NEUROLOGY
- Accuracy of a Panel of 5 Cerebrospinal Fluid Biomarkers in the Differential Diagnosis of Patients With Dementia and/or Parkinsonian Disorders
- (2012) Sara Hall et al. ARCHIVES OF NEUROLOGY
- Arginine methylation next to the PY-NLS modulates Transportin binding and nuclear import of FUS
- (2012) Dorothee Dormann et al. EMBO JOURNAL
- Increased 3-Hydroxykynurenine serum concentrations differentiate Alzheimer’s disease patients from controls
- (2012) Markus J. Schwarz et al. EUROPEAN ARCHIVES OF PSYCHIATRY AND CLINICAL NEUROSCIENCE
- Comparison of ultracentrifugation, density gradient separation, and immunoaffinity capture methods for isolating human colon cancer cell line LIM1863-derived exosomes
- (2012) Bow J. Tauro et al. METHODS
- Brain amyloid and cognition in Lewy body diseases
- (2012) Stephen N. Gomperts et al. MOVEMENT DISORDERS
- Plasma Based Markers of [11C] PiB-PET Brain Amyloid Burden
- (2012) Steven John Kiddle et al. PLoS One
- Tau proteins in serum predict neurological outcome after hypoxic brain injury from cardiac arrest: Results of a pilot study
- (2012) Jeffrey Randall et al. RESUSCITATION
- Application of metabolomics approaches to the study of respiratory diseases
- (2012) Stuart Snowden et al. Bioanalysis
- Toward defining the preclinical stages of Alzheimer’s disease: Recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease
- (2011) Reisa A. Sperling et al. Alzheimers & Dementia
- The diagnosis of dementia due to Alzheimer’s disease: Recommendations from the National Institute on Aging-Alzheimer’s Association workgroups on diagnostic guidelines for Alzheimer's disease
- (2011) Guy M. McKhann et al. Alzheimers & Dementia
- The diagnosis of mild cognitive impairment due to Alzheimer’s disease: Recommendations from the National Institute on Aging-Alzheimer’s Association workgroups on diagnostic guidelines for Alzheimer's disease
- (2011) Marilyn S. Albert et al. Alzheimers & Dementia
- Quantitative proteomic analysis of serum proteins in patients with Parkinson’s disease using an isobaric tag for relative and absolute quantification labeling, two-dimensional liquid chromatography, and tandem mass spectrometry
- (2011) Xiaping Zhang et al. ANALYST
- Sensitivity of revised diagnostic criteria for the behavioural variant of frontotemporal dementia
- (2011) Katya Rascovsky et al. BRAIN
- Amyloid P component as a plasma marker for Parkinson's disease identified by a proteomic approach
- (2011) Han-Min Chen et al. CLINICAL BIOCHEMISTRY
- Diagnostic Accuracy of Plasma Glial Fibrillary Acidic Protein for Differentiating Intracerebral Hemorrhage and Cerebral Ischemia in Patients with Symptoms of Acute Stroke
- (2011) C. Foerch et al. CLINICAL CHEMISTRY
- Serum tau protein as a marker for the diagnosis of Creutzfeldt-Jakob disease
- (2011) Moeko Noguchi-Shinohara et al. JOURNAL OF NEUROLOGY
- Amyloid Imaging with 18F-Florbetaben in Alzheimer Disease and Other Dementias
- (2011) V. L. Villemagne et al. JOURNAL OF NUCLEAR MEDICINE
- Gains or losses: molecular mechanisms of TDP43-mediated neurodegeneration
- (2011) Edward B. Lee et al. NATURE REVIEWS NEUROSCIENCE
- Amyloid-related biomarkers and axonal damage proteins in parkinsonian syndromes
- (2011) Sara Bech et al. PARKINSONISM & RELATED DISORDERS
- Metabolomics in Early Alzheimer's Disease: Identification of Altered Plasma Sphingolipidome Using Shotgun Lipidomics
- (2011) Xianlin Han et al. PLoS One
- Plasma Biomarkers of Brain Atrophy in Alzheimer's Disease
- (2011) Madhav Thambisetty et al. PLoS One
- Metabolome in progression to Alzheimer's disease
- (2011) M Orešič et al. Translational Psychiatry
- Kynurenine and its metabolites in Alzheimer's disease patients
- (2010) E Gulaj et al. Advances in Medical Sciences
- Metabolomic changes in autopsy-confirmed Alzheimer's disease
- (2010) Rima Kaddurah-Daouk et al. Alzheimers & Dementia
- Parkinson's disease dementia: Definitions, guidelines, and research perspectives in diagnosis
- (2010) Christopher G. Goetz et al. ANNALS OF NEUROLOGY
- Axonal damage in relapsing multiple sclerosis is markedly reduced by natalizumab
- (2010) Martin Gunnarsson et al. ANNALS OF NEUROLOGY
- Neurogranin in cerebrospinal fluid as a marker of synaptic degeneration in Alzheimer's disease
- (2010) Annika Thorsell et al. BRAIN RESEARCH
- Brain-specific fatty acid-binding protein is elevated in serum of patients with dementia-related diseases
- (2010) C. E. Teunissen et al. EUROPEAN JOURNAL OF NEUROLOGY
- The cognitive profile and CSF biomarkers in dementia with Lewy bodies and Parkinson's disease dementia
- (2010) M. Andersson et al. INTERNATIONAL JOURNAL OF GERIATRIC PSYCHIATRY
- Differential levels of -synuclein, -amyloid42 and tau in CSF between patients with dementia with Lewy bodies and Alzheimer's disease
- (2010) K. Kasuga et al. JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY
- Potential of advanced MR imaging techniques in the differential diagnosis of parkinsonism
- (2010) Anna Hotter et al. MOVEMENT DISORDERS
- Significance of MRI in Diagnosis and Differential Diagnosis of Parkinson’s Disease
- (2010) Philipp Mahlknecht et al. Neurodegenerative Diseases
- Plasma phosphorylated-TDP-43 protein levels correlate with brain pathology in frontotemporal lobar degeneration
- (2009) Penelope G. Foulds et al. ACTA NEUROPATHOLOGICA
- Approaching clinical proteomics: current state and future fields of application in fluid proteomics
- (2009) Rolf Apweiler et al. CLINICAL CHEMISTRY AND LABORATORY MEDICINE
- Neuroprotective effects of naturally occurring polyphenols on quinolinic acid-induced excitotoxicity in human neurons
- (2009) Nady Braidy et al. FEBS Journal
- Categorical and correlational analyses of baseline fluorodeoxyglucose positron emission tomography images from the Alzheimer's Disease Neuroimaging Initiative (ADNI)
- (2009) Jessica B.S. Langbaum et al. NEUROIMAGE
- Differential diagnosis of parkinsonian syndromes using PCA-based functional imaging features
- (2009) Phoebe G. Spetsieris et al. NEUROIMAGE
- Mutations in FUS, an RNA Processing Protein, Cause Familial Amyotrophic Lateral Sclerosis Type 6
- (2009) C. Vance et al. SCIENCE
- Mutations in the FUS/TLS Gene on Chromosome 16 Cause Familial Amyotrophic Lateral Sclerosis
- (2009) T. J. Kwiatkowski et al. SCIENCE
- TDP-43 protein in plasma may index TDP-43 brain pathology in Alzheimer’s disease and frontotemporal lobar degeneration
- (2008) Penelope Foulds et al. ACTA NEUROPATHOLOGICA
- CSF Multianalyte Profile Distinguishes Alzheimer and Parkinson Diseases
- (2008) Jing Zhang et al. AMERICAN JOURNAL OF CLINICAL PATHOLOGY
- TDP-43 in Cerebrospinal Fluid of Patients With Frontotemporal Lobar Degeneration and Amyotrophic Lateral Sclerosis
- (2008) Petra Steinacker et al. ARCHIVES OF NEUROLOGY
- Metabolomic profiling to develop blood biomarkers for Parkinson's disease
- (2008) M. Bogdanov et al. BRAIN
- Individual cerebral metabolic deficits in Alzheimer’s disease and amnestic mild cognitive impairment: an FDG PET study
- (2008) Angelo Del Sole et al. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
- Amyloid load in Parkinson's disease dementia and Lewy body dementia measured with [11C]PIB positron emission tomography
- (2008) P Edison et al. JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY
- Evaluation of plasma Aβ40 and Aβ42 as predictors of conversion to Alzheimer's disease in patients with mild cognitive impairment
- (2008) Oskar Hansson et al. NEUROBIOLOGY OF AGING
- Imaging amyloid deposition in Lewy body diseases
- (2008) S. N. Gomperts et al. NEUROLOGY
- Uric acid associates with cognition in Parkinson's disease
- (2008) Tua Annanmaki et al. PARKINSONISM & RELATED DISORDERS
- Stability of Pro-Gastrin-Releasing Peptide in Serum versus Plasma
- (2008) Toru Yoshimura et al. TUMOR BIOLOGY
- Serum heart-fatty acid binding protein levels in patients with Lewy body disease
- (2007) Kenji Wada-Isoe et al. JOURNAL OF THE NEUROLOGICAL SCIENCES
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started